Paul, Weiss, Rifkind, wharton & Garrison LLP


Recent News About Paul, Weiss, Rifkind, wharton & Garrison LLP View More

Drug maker AbbVie wants to slip from $140M verdict, says jury ignored evidence

By Dan Churney | Nov 6, 2017

North Chicago-based drug company AbbVie is urging a federal judge to trash a verdict ordering it to cough up $140 million, because its testosterone therapy drug AndroGel contributed to a man's heart attack, contending it has no liability because AndroGel was approved by the FDA.

Jury: Abbvie falsely marketed Androgel, owes man who suffered heart attack $140M

By Jonathan Bilyk | Oct 5, 2017

Drugmaker Abbvie has suffered another big loss in court, as a Chicago federal jury has ordered the North Chicago-based pharmaceutical company to pay out $140 million to another man who claimed he had suffered a heart attack as a result of taking Abbvie’s testosterone therapy drug, Androgel.

Consumers too far down distribution chain to press price fixing class action vs steelmakers, says judge

By Dan Churney | Mar 13, 2017

A group of steel makers, led by Chicago-based ArcelorMittal USA, have beaten down a class-action antitrust lawsuit filed by more than a dozen consumers, who alleged the companies schemed to raise prices for goods made with steel, by pointing out the consumers were too far down the distribution line from the steel manufacturers to claim losses. 

The Record Network